News

Kalydeco is indicated for people with CF who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene. Vertex Global Research

The company expects to launch its patented brand formulation of the acne medication isotretinoin in the fourth quarter of 2012, in the US. Cipher president and CEO Larry

The company anticipates the approval of production in the next three months and plans to introduce the drug in the second half of the 2012. Sihuan chairman and

The European Commission, which has the authority to approve medicines for the EU, will review CHMP’s positive opinion. Pfizer Oncology Business Unit clinical development and medical affairs senior

The bill gives US regulators new tools to combat drug counterfeiting and shortages while allowing inspecting more drug manufacturing facilities in China, India and other foreign countries, The

The TrueDX platform helps physicians to determine whether a patient suffers from a hypoactive thyroid and the TSH test enables doctors and patients to gain access to diagnosis,

The study is designed to evaluate the safety, tolerability and pharmacokinetics of XP23829, including confirmation of its conversion to monomethyl fumarate (MMF). The performance of four novel formulations

The lawsuit was filed in the US District Court for the District of New Jersey in response to a notice letter sent by Watson Laboratories regarding ANDA filing

The announcement follows a month-long inspection programme by SFDA who found that of the 11,561 batches of drugs tested, 5.8% were found to contain excessive levels of chromium.